Neuroone Medical Technologies (NMTC) Operating Income (2011 - 2026)

Neuroone Medical Technologies (NMTC) has reported Operating Income for 16 consecutive years, with -$2.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Income fell 28.5% year-over-year to -$2.4 million; the trailing twelve-month figure through Jun 2026 stood at -$7.9 million (down 39.28% YoY), and the FY2025 full-year result was -$4.2 million, up 64.45% from the prior year.
• Operating Income fell to -$2.4 million in Q2 2026 per NMTC's latest filing, from -$2.4 million in the prior quarter.
• Across five years, Operating Income topped out at $1.7 million in Q4 2024 and bottomed at -$3.5 million in Q2 2023.
• Historically, Operating Income has averaged -$2.3 million across 5 years, with a median of -$2.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Operating Income jumped 150.47% in 2024, then sank 199.77% in 2025.
• Over 5 years, Operating Income stood at -$1.8 million in 2022, then tumbled by 90.01% to -$3.4 million in 2023, then surged by 150.47% to $1.7 million in 2024, then plunged by 199.77% to -$1.7 million in 2025, then sank by 42.0% to -$2.4 million in 2026.
• According to Business Quant data, Operating Income over the past three periods registered -$2.4 million, -$2.4 million, and -$1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.